| abstract |
The present invention involves compounds having the structure: ##STR1## wherein: (a) --A 1 is selected from the group consisting of --OH, --H, and --O 2 CR; n (b) --A 2 is selected from the group consisting of unsubstituted or substituted, saturated or unsaturated, straight, branched and cyclic alkyl having from 1 to about 10 carbon atoms; n (c)--A 3 is selected from --C(CH 3 ) 3 , --Si(CH 3 ) 3 , and --CF 3 ; and n (d) --Y is selected from certain low molecular weight alkyl chains which terminate in specific unsaturated functional groups: ##STR2## and aldehydes in the form of their acetals; pharmaceutical compositions comprising such compounds; and methods for treating inflammation by administering such compounds. |